TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 153 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q4 2015. The put-call ratio across all filers is 0.80 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $237,762 | +11.6% | 6,305 | +12.2% | 0.00% | – |
| Q2 2023 | $213,091 | +399.3% | 5,618 | +220.1% | 0.00% | – |
| Q1 2023 | $42,682 | -16.3% | 1,755 | 0.0% | 0.00% | – |
| Q4 2022 | $50,965 | -19.1% | 1,755 | 0.0% | 0.00% | – |
| Q2 2022 | $63,000 | +5.0% | 1,755 | +26.7% | 0.00% | – |
| Q1 2022 | $60,000 | -13.0% | 1,385 | 0.0% | 0.00% | – |
| Q4 2021 | $69,000 | -29.6% | 1,385 | -10.0% | 0.00% | – |
| Q3 2021 | $98,000 | -11.7% | 1,539 | 0.0% | 0.00% | – |
| Q2 2021 | $111,000 | +117.6% | 1,539 | +120.8% | 0.00% | – |
| Q1 2021 | $51,000 | -92.6% | 697 | -92.6% | 0.00% | – |
| Q4 2020 | $687,000 | +33.9% | 9,358 | 0.0% | 0.00% | – |
| Q3 2020 | $513,000 | -30.0% | 9,358 | -15.1% | 0.00% | -100.0% |
| Q2 2020 | $733,000 | -36.0% | 11,019 | -41.1% | 0.00% | 0.0% |
| Q1 2020 | $1,145,000 | +249.1% | 18,716 | +329.6% | 0.00% | – |
| Q3 2019 | $328,000 | -16.1% | 4,357 | -4.9% | 0.00% | – |
| Q2 2019 | $391,000 | -16.8% | 4,580 | +5.1% | 0.00% | – |
| Q1 2019 | $470,000 | +27.7% | 4,357 | 0.0% | 0.00% | – |
| Q4 2018 | $368,000 | -85.0% | 4,357 | -82.6% | 0.00% | -100.0% |
| Q3 2018 | $2,454,000 | +144.4% | 24,978 | +187.6% | 0.00% | – |
| Q2 2018 | $1,004,000 | +47.2% | 8,684 | +25.6% | 0.00% | – |
| Q1 2018 | $682,000 | +10.7% | 6,916 | +17.4% | 0.00% | – |
| Q4 2017 | $616,000 | -91.3% | 5,893 | -90.7% | 0.00% | -100.0% |
| Q3 2017 | $7,111,000 | -9.9% | 63,110 | -10.4% | 0.01% | -16.7% |
| Q2 2017 | $7,895,000 | +245.7% | 70,464 | +259.5% | 0.01% | +200.0% |
| Q1 2017 | $2,284,000 | -81.6% | 19,600 | -83.4% | 0.00% | -80.0% |
| Q4 2016 | $12,391,000 | +18.2% | 117,721 | +24.1% | 0.01% | +42.9% |
| Q3 2016 | $10,479,000 | -16.5% | 94,827 | +10.0% | 0.01% | -22.2% |
| Q2 2016 | $12,553,000 | +417.9% | 86,234 | +409.4% | 0.01% | +350.0% |
| Q1 2016 | $2,424,000 | +78.0% | 16,929 | +92.0% | 0.00% | +100.0% |
| Q4 2015 | $1,362,000 | -53.7% | 8,818 | -57.1% | 0.00% | -50.0% |
| Q3 2015 | $2,939,000 | -30.7% | 20,575 | -30.3% | 0.00% | -33.3% |
| Q2 2015 | $4,242,000 | +20.2% | 29,527 | +18.0% | 0.00% | +50.0% |
| Q1 2015 | $3,529,000 | +905.4% | 25,030 | +956.6% | 0.00% | – |
| Q4 2014 | $351,000 | -51.0% | 2,369 | -49.1% | 0.00% | – |
| Q3 2014 | $716,000 | +10128.6% | 4,655 | +4905.4% | 0.00% | – |
| Q3 2013 | $7,000 | – | 93 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ISZO CAPITAL MANAGEMENT LP | 582,409 | $90,011,000 | 60.33% |
| GUARDIAN POINT CAPITAL, LP | 70,000 | $10,819,000 | 10.19% |
| Think Investments LP | 186,373 | $28,804,000 | 8.16% |
| Greywolf Capital Management LP | 277,936 | $42,955,000 | 7.45% |
| Valentine Capital Asset Management, Inc. | 28,431 | $4,394,000 | 4.91% |
| FORT, L.P. | 63,675 | $9,841,000 | 4.69% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 527,266 | $81,489,000 | 3.63% |
| RPG Investment Advisory, LLC | 60,910 | $9,413,000 | 3.52% |
| Kerrisdale Advisers, LLC | 81,996 | $12,672,000 | 3.24% |
| Strategic Global Advisors, LLC | 48,154 | $7,442,000 | 3.17% |